Apricot Capital (Shanghai) Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 2

Professionals

  • Investments
  • 103

  • Portfolio
  • 57

  • Exits
  • 15

Exits

Apricot Capital (Shanghai) General Information

Company Description

Founded in 2015, Apricot Capital is a venture capital firm based in Shanghai, China. The firm seeks to invest in the healthcare sector.

Business Details

Website
www.apricot-capital.com
Year Founded
2015
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Corporate Office
  • Number 1479, Fuxing Middle Road
  • Shanghai
  • China
+86 021

Apricot Capital (Shanghai) Investments (103)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
BCIFlex 21-Sep-2026 Early Stage VC Therapeutic Devices Generating Revenue
iRegene 01-Jun-2026 Drug Discovery Generating Revenue
Lync Bio 19-May-2026 Drug Discovery Generating Revenue
VIVACTA Biotechnology 13-Apr-2026 Drug Discovery Generating Revenue
Vivatides Therapeutics 10-Apr-2026 Drug Discovery Startup
Weicheng Pharmaceuticals 09-Apr-2026 Drug Delivery Generating Revenue
Aikelian Biotechnology 18-Mar-2026 Biotechnology Startup
BCIFlex 11-Feb-2026 Therapeutic Devices Generating Revenue
VIVACTA Biotechnology 26-Jan-2026 Early Stage VC Drug Discovery Generating Revenue
QL Biopharm 19-Jan-2026 Later Stage VC Drug Discovery Generating Revenue
You’re viewing 10 of 103 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Apricot Capital (Shanghai) Exits (15)

Company Name Exit Date Exit Type Exit Size
Evopoint Biosciences 16-Sep-2026 IPO
CirCode 15-Jul-2025
Argo Biopharma 26-Nov-2024
MicroPort Electrophysiology 30-Aug-2022
Shanghai Shengsheng 09-Nov-2021
ETERN Therapeutics 04-Nov-2021
Guobang Pharmaceutical 02-Aug-2021
Akesobio 24-Apr-2020
SinoMab Bioscience 12-Nov-2019 IPO
Junshi Biosciences 24-Dec-2018 IPO
You’re viewing 10 of 15 exits. Get the full list »

Apricot Capital (Shanghai) Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Apricot Capital (Shanghai) FAQs

  • What is Apricot Capital (Shanghai)?

    Founded in 2015, Apricot Capital is a venture capital firm based in Shanghai, China.

  • When was Apricot Capital (Shanghai) founded?

    Apricot Capital (Shanghai) was founded in 2015.

  • Where is Apricot Capital (Shanghai) headquartered?

    Apricot Capital (Shanghai) is headquartered in Shanghai, China.

  • What is Apricot Capital (Shanghai)'s total asset value?

    Apricot Capital (Shanghai) has around in total assets under management.

  • How many investments has Apricot Capital (Shanghai) made?

    Apricot Capital (Shanghai) has made 103 investments.

  • What has Apricot Capital (Shanghai) invested in?

    Apricot Capital (Shanghai) has made numerous investments in companies like BCIFlex, iRegene, and Lync Bio within the Therapeutic Devices and Drug Discovery industries.

  • What has Apricot Capital (Shanghai) invested in recently?

    Apricot Capital (Shanghai)'s latest investment was on 21-Sep-2026 in BCIFlex, a company within the Therapeutic Devices industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process